Table 3.
(a) Determine the absolute count of the following lymphocyte subpopulations, and compare the results with age-matched reference values | |||
CD3+ | T lymphocytes | ||
CD3+/CD4+ | Helper-T lymphocytes | ||
CD3+/CD8+ | Cytotoxic T lymphocytes | ||
CD3+/HLA-DR+ | Activated T lymphocytes | ||
CD3+/CD4–/CD8– | ‘Double-negative’ T cells | ||
CD3+/TCR-γδ+ | Subset of T lymphocytes | ||
CD19+ or CD20+ | B lymphocytes | ||
CD3–/CD16+ and/or CD56+ | NK cells | ||
(b) Determine the uptake of [3H]-thymidine (or CFSE or activation markers) and compare the results with − preferably − age-matched controls after stimulation with: | Mitogens (e.g. PHA, PMA + ionomycin, PWM) | ||
Consider monoclonal antibodies (e.g. CD2 ± CD28, CD3 ± CD28) | |||
Antigens (e.g. tetanus, after booster vaccination) | |||
Consider allogeneic cells |
(a) Can be performed in many hospitals; for correct interpretation of the results, the advice of an immunologist is highly recommended. (b) Collaboration with an immunologist and specialized laboratory is recommended.
Abbreviations: CD = cluster of differentiation, CFSE = carboxyfluorescein succinimidyl ester, HLA = human leucocyte antigen, NK = natural killer, PHA = phytohaemagglutinin, PMA = phorbol myristate acetate, PWM = pokeweed mitogen, TCR = T-cell receptor.